Antiangiogenic tyrosine kinase inhibition related gastrointestinal perforations: a case report and literature review.
about
Rapid angiogenesis onset after discontinuation of sunitinib treatment of renal cell carcinoma patientsSafety of endoscopy in cancer patients on antiangiogenic agents: A retrospective multicenter outcomes study.Risk of oral and gastrointestinal mucosal injury in patients with solid tumors treated with ramucirumab: a systematic review and meta-analysis.Imaging features of bowel toxicities in the setting of molecular targeted therapies in cancer patients.Campylobacteremia in stage IV gliosarcoma with bevacizumab treatment.Pneumatosis intestinalis after gefitinib therapy for pulmonary adenocarcinoma: a case report.Tumor control versus adverse events with targeted anticancer therapies.What the emergency radiologist needs to know about treatment-related complications from conventional chemotherapy and newer molecular targeted agents.Risk of gastrointestinal perforation in cancer patients treated with aflibercept: a systematic review and meta-analysis.Extensive bowel necrosis related to bevacizumab in metastatic rectal cancer patient: a case report and review of literature.Bowel Perforation After Treatment with Sorafenib: A Case Report and Review of Literature.Stercoral Ulcer-Associated Perforation and Chemotherapy.Risk of gastrointestinal perforation in cancer patients receiving ramucirumab: a meta-analysis of randomized controlled trials.Intensity-modulated radiotherapy for hepatocellular carcinoma: dosimetric and clinical results.Perforation of the Colon During Imatinib Mesylate (Gleevec) Treatment in a Patient with Chronic Myeloid Leukemia (CML).Gastrointestinal perforation related to lenvatinib, an anti-angiogenic inhibitor that targets multiple receptor tyrosine kinases, in a patient with metastatic thyroid cancer.Gastric perforation related to concurrent use of nintedanib and ramucirumab
P2860
Q33588739-05591D98-B8F2-43D5-96C1-695BCD5ED8D9Q33637887-DB88B2E3-6A2B-4154-A149-175749F43A37Q35757310-E2E86207-F471-4433-9A58-8490BF0CD4E3Q36325837-354293C0-7E0F-4D9A-BE36-72AC84F9E10AQ37021357-700C5FE4-CBCB-4BD6-BBAF-3471B0D21EC3Q37154110-2B132C7A-0B4B-45E7-B9B2-7080B4A79C5BQ37969899-D15738BA-ADF3-4CB1-A476-B2954C3D4EC6Q38016741-FD476B55-49C2-4C1F-BB18-04BFE91EEF33Q38234800-D5498A73-D8A4-46B6-A39F-7D9586A65035Q38285628-A7D637A2-EC08-4A61-9F1F-736CED467D6BQ38557035-1EA1E58D-7F0F-4ED5-8503-64942AC94A1DQ41112373-158C07E5-43E3-4752-91D9-E6797A963D4DQ41650735-42DD68E2-D9F7-44E5-AAD1-04C08704CE8EQ41709047-31EBC1C4-3F12-488E-802C-78E3240D1593Q42399372-EA86574E-ED81-411C-9151-FB27A59AA0A4Q48212500-5EE681B5-7C74-462E-9826-9A0E6D372928Q59137087-48F6AE5D-7EF1-4527-8FE8-99A7A4C9E21E
P2860
Antiangiogenic tyrosine kinase inhibition related gastrointestinal perforations: a case report and literature review.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Antiangiogenic tyrosine kinase ...... report and literature review.
@ast
Antiangiogenic tyrosine kinase ...... report and literature review.
@en
type
label
Antiangiogenic tyrosine kinase ...... report and literature review.
@ast
Antiangiogenic tyrosine kinase ...... report and literature review.
@en
prefLabel
Antiangiogenic tyrosine kinase ...... report and literature review.
@ast
Antiangiogenic tyrosine kinase ...... report and literature review.
@en
P2093
P2860
P1433
P1476
Antiangiogenic tyrosine kinase ...... report and literature review.
@en
P2093
Emile E Voest
H M W Verheul
Martijn P J Lolkema
Maudy Walraven
Petronella O Witteveen
R van Hillegersberg
P2860
P2888
P304
P356
10.1007/S10456-010-9197-6
P577
2010-12-29T00:00:00Z
2011-05-01T00:00:00Z